Insulin infusions are widely endorsed to quickly achieve and maintain glucose control, but iatrogenic fluctuations in blood glucose caused by inappropriate insulin therapies in patients with type 2 diabetes may exacerbate oxidative stress and endothelial dysfunction, thereby increasing the risk of macrovascular complications [26]. The gene discussed is INS; the disease is endothelial dysfunction.